HEOR & Market Access Research
Demonstrate clinical and economic value to payers, health technology assessment bodies, and healthcare decision-makers.
Demonstrating Value Beyond Efficacy
Payers increasingly require evidence showing real-world clinical and economic value before granting reimbursement access.
Our Solutions
- Cost-Effectiveness AnalysisEvaluate clinical outcomes relative to costs.
- Budget Impact AnalysisEstimate financial consequences for healthcare systems.
- Economic ModelingSupport reimbursement and pricing strategies.
- Value DossiersCommunicate product value effectively.
- Comparative Effectiveness ResearchGenerate evidence supporting treatment differentiation.
Whether you need support with evidence generation, epidemiology, outcomes research, health economics, or advanced analytics, York HEOR Group is ready to help.
Deliverables
- HEOR Models
- HTA Support Materials
- Value Communication Tools
- Reimbursement Evidence Packages
Related Services
Develop targeted evidence-generation plans that address critical business, regulatory, and clinical questions.
Generate insights into prevalence, incidence, disease progression, and unmet medical needs.
Deliver advanced statistical analysis and programming support using industry-leading methodologies and platforms.
Frequently Asked Questions
What is HEOR?
Health economics and outcomes research evaluates the clinical, economic, and humanistic outcomes of healthcare interventions. Payers use it in reimbursement decisions.
What does HEOR do in pharma?
It shows that a medicine offers value beyond efficacy, through economic models, value dossiers, and health technology assessment evidence that support market access.
What evidence do payers look for?
Better outcomes for patients at an acceptable cost: comparative effectiveness, real-world outcomes, cost-effectiveness, and the budget impact on their health system.
What is a QALY?
A quality-adjusted life year combines length of life with quality of life. One QALY equals one year in perfect health and is used in cost-effectiveness analyses.
What is the difference between budget impact analysis and cost-effectiveness analysis?
Cost-effectiveness analysis asks whether a treatment is good value for its health benefits. Budget impact analysis asks whether a health system can afford it.
Let's Discuss Your Research Goals
Schedule a Consultation Today and learn how York HEOR Group can transform your healthcare data into evidence-driven decisions.